P3.03-046 Prognostic Fibrinogen/Leucocyte Score at Diagnosis Predicts Survival and Benefit from Multimodality Treatment in MPM Topic: Mesothelioma Clinical
Klikovits T, Bertoglio P, Ambrogi M, Stockhammer P, Dong Y, Dome B, Laszlo V, Klepetko W, Mussi A, Hoda M. P3.03-046 Prognostic Fibrinogen/Leucocyte Score at Diagnosis Predicts Survival and Benefit from Multimodality Treatment in MPM Topic: Mesothelioma Clinical. Journal Of Thoracic Oncology 2017, 12: s1374. DOI: 10.1016/j.jtho.2016.11.1945.Peer-Reviewed Original ResearchMultimodality treatmentClinical